AP52A - Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoy) -2-oxindole-1-carboxamide. - Google Patents

Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoy) -2-oxindole-1-carboxamide. Download PDF

Info

Publication number
AP52A
AP52A APAP/P/1988/000081A AP8800081A AP52A AP 52 A AP52 A AP 52A AP 8800081 A AP8800081 A AP 8800081A AP 52 A AP52 A AP 52A
Authority
AP
ARIPO
Prior art keywords
sodium salt
anhydrous
oxindole
carboxamide
chloro
Prior art date
Application number
APAP/P/1988/000081A
Other languages
English (en)
Other versions
AP8800081A0 (en
Inventor
Douglas John Meldrum Allen
Brian Thomas O'neil
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of AP8800081A0 publication Critical patent/AP8800081A0/xx
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AP52A publication Critical patent/AP52A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
APAP/P/1988/000081A 1987-02-02 1988-01-28 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoy) -2-oxindole-1-carboxamide. AP52A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (2)

Publication Number Publication Date
AP8800081A0 AP8800081A0 (en) 1987-11-01
AP52A true AP52A (en) 1989-09-16

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1988/000081A AP52A (en) 1987-02-02 1988-01-28 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoy) -2-oxindole-1-carboxamide.

Country Status (42)

Country Link
US (1) US5036099A (fi)
EP (1) EP0277738B1 (fi)
JP (1) JPS63201184A (fi)
KR (1) KR900001422B1 (fi)
CN (1) CN1022324C (fi)
AP (1) AP52A (fi)
AR (1) AR243182A1 (fi)
AT (1) ATE73800T1 (fi)
AU (1) AU587736B2 (fi)
BG (1) BG51042A3 (fi)
CA (1) CA1335590C (fi)
CS (2) CS265250B2 (fi)
CY (1) CY1775A (fi)
DD (1) DD267490A5 (fi)
DE (1) DE3869149D1 (fi)
DK (1) DK44888A (fi)
EC (1) ECSP941082A (fi)
ES (1) ES2032955T3 (fi)
FI (1) FI89598C (fi)
GR (1) GR3004200T3 (fi)
HK (1) HK132695A (fi)
IE (1) IE60000B1 (fi)
IL (1) IL85277A (fi)
IN (1) IN171799B (fi)
IS (1) IS1533B (fi)
LV (1) LV10252B (fi)
MA (1) MA21171A1 (fi)
MY (1) MY102737A (fi)
NO (1) NO170581C (fi)
NZ (1) NZ223373A (fi)
OA (1) OA08710A (fi)
PH (1) PH26545A (fi)
PL (1) PL149550B1 (fi)
PT (1) PT86675B (fi)
RO (1) RO105052B1 (fi)
RU (1) RU2011381C1 (fi)
SG (1) SG27994G (fi)
SI (1) SI8810183A8 (fi)
UA (1) UA25898A1 (fi)
WO (1) WO1988005656A1 (fi)
YU (1) YU46766B (fi)
ZA (1) ZA88679B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5118703A (en) * 1988-10-18 1992-06-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
IL274383B2 (en) 2017-11-02 2024-03-01 Accurate Medical Therapeutics Ltd Catheter for embolization with integral filter

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
EP0155828B1 (en) * 1984-03-19 1990-09-19 Pfizer Inc. Process for making 2-oxindole-1-carboxamides and intermediates therefor
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents

Also Published As

Publication number Publication date
ECSP941082A (es) 1994-12-15
IL85277A (en) 1994-02-27
OA08710A (fr) 1989-03-31
DE3869149D1 (de) 1992-04-23
SG27994G (en) 1994-10-14
SI8810183A8 (sl) 1996-08-31
PL270415A1 (en) 1988-12-08
YU18388A (en) 1989-10-31
GR3004200T3 (fi) 1993-03-31
AP8800081A0 (en) 1987-11-01
DK44888A (da) 1988-08-03
YU46766B (sh) 1994-05-10
NO884329L (no) 1988-09-29
KR900001422B1 (ko) 1990-03-09
US5036099A (en) 1991-07-30
CS64888A2 (en) 1988-08-16
DK44888D0 (da) 1988-01-29
MY102737A (en) 1992-09-30
ATE73800T1 (de) 1992-04-15
DD267490A5 (de) 1989-05-03
CS354191A3 (en) 1992-04-15
EP0277738B1 (en) 1992-03-18
CN88100555A (zh) 1988-08-17
NO170581C (no) 1992-11-04
IE60000B1 (en) 1994-05-18
WO1988005656A1 (en) 1988-08-11
IS3309A7 (is) 1988-08-03
FI893647A0 (fi) 1989-08-01
BG51042A3 (en) 1993-01-15
KR880009961A (ko) 1988-10-06
MA21171A1 (fr) 1988-10-01
NZ223373A (en) 1989-06-28
IS1533B (is) 1994-01-28
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
HK132695A (en) 1995-09-01
CN1022324C (zh) 1993-10-06
JPH0576945B2 (fi) 1993-10-25
IE880269L (en) 1988-08-02
NO170581B (no) 1992-07-27
PL149550B1 (en) 1990-02-28
RO105052B1 (en) 1994-12-01
IN171799B (fi) 1993-01-09
UA25898A1 (uk) 1999-02-26
AU1116088A (en) 1988-08-04
IL85277A0 (en) 1988-07-31
FI89598B (fi) 1993-07-15
CY1775A (en) 1996-04-05
FI89598C (fi) 1993-10-25
AU587736B2 (en) 1989-08-24
PT86675A (pt) 1988-03-01
NO884329D0 (no) 1988-09-29
ZA88679B (en) 1989-09-27
CS265250B2 (en) 1989-10-13
ES2032955T3 (es) 1996-07-16
RU2011381C1 (ru) 1994-04-30
PH26545A (en) 1992-08-19
EP0277738A1 (en) 1988-08-10
LV10252A (lv) 1994-10-20
PT86675B (pt) 1992-07-31
AR243182A1 (es) 1993-07-30
CA1335590C (en) 1995-05-16

Similar Documents

Publication Publication Date Title
AP52A (en) Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoy) -2-oxindole-1-carboxamide.
RU2177000C2 (ru) Способ приготовления амлодипин бензолсульфоната
JP2001500878A (ja) オランザピン二水和物ｄ
WO2004013147A1 (en) Racemization and enantiomer separation of clopidogrel
NO312514B1 (no) Mesylat-dihydratsalter av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1- piperazinyl)-etyl)-6-klor-1,3-dihydro-2(1H)-indol-2-on(ziprazidone), og farmasöytisk blanding for behandling av enpsykotisk forstyrrelse
ZA200509155B (en) Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
BE1014453A6 (nl) Amlodipinefumaraat.
JP2006500320A (ja) カルベジロール一クエン酸塩一水和物
WO2002053539A1 (en) Amlodipine hemimaleate
KR101145433B1 (ko) 로시글리타존 말레이트의 다형을 제조하는 방법
DK200300114U3 (da) Faste tilstandsformer af ondansetron
JP3931884B2 (ja) 錠剤の製造方法
BG62228B2 (bg) безводна кристална натриева сол на 5-хлор-3-(2-теноил)-2- оксиндол-1-карбоксамид
HU211140A9 (hu) Az 5-klór-3-(2*tenoil)-2-oxindol-1-karboxamid vízmentes, kristályos nátriumsója
JP3900302B2 (ja) 結晶性ｌ−アスパラギン酸カルシウムの製造方法
KR101120120B1 (ko) 무정형 아데포비아 디피복실을 포함하는 약학 조성물 및 이의 제조 방법
JPH10265387A (ja) 腎炎治療剤
CZ12566U1 (cs) Amlodipinhemimaleát a farmaceutický prostředek
CZ12615U1 (cs) Směsná sůl amlodipinfumarátu, farmaceutický prostředek, a použití
SI21067A2 (sl) Amlodipin hemimaleat